113 related articles for article (PubMed ID: 16000888)
1. A comparison of two progestins on myocardial ischemia-reperfusion injury in ovariectomized monkeys receiving estrogen therapy.
Suparto IH; Koudy Williams J; Fox JL; Vinten-Johansen J
Coron Artery Dis; 2005 Aug; 16(5):301-8. PubMed ID: 16000888
[TBL] [Abstract][Full Text] [Related]
2. Different cerebrovascular effects of medroxyprogesterone acetate and norethisterone acetate in the New Zealand White rabbit.
Pedersen SH; Pedersen NG; Dalsgaard T; Lund CO; Nilas L; Ottesen B
Climacteric; 2004 Mar; 7(1):12-22. PubMed ID: 15259279
[TBL] [Abstract][Full Text] [Related]
3. Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits.
Pedersen NG; Pedersen SH; Dalsgaard T; Lund CO; Nilas L; Ottesen B
Maturitas; 2004 Dec; 49(4):304-14. PubMed ID: 15531126
[TBL] [Abstract][Full Text] [Related]
4. Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys.
Suparto IH; Williams JK; Cline JM; Anthony MS; Fox JL
Am J Obstet Gynecol; 2003 May; 188(5):1132-40. PubMed ID: 12748457
[TBL] [Abstract][Full Text] [Related]
5. Effects of hormone therapy and dietary soy on myocardial ischemia/reperfusion injury in ovariectomized atherosclerotic monkeys.
Suparto IH; Williams JK; Fox JL; Yusuf JT; Sajuthi D
Menopause; 2008; 15(2):256-63. PubMed ID: 17917613
[TBL] [Abstract][Full Text] [Related]
6. A comparison of progestins within three classes: Differential effects on learning and memory in the aging surgically menopausal rat.
Braden BB; Andrews MG; Acosta JI; Mennenga SE; Lavery C; Bimonte-Nelson HA
Behav Brain Res; 2017 Mar; 322(Pt B):258-268. PubMed ID: 27368418
[TBL] [Abstract][Full Text] [Related]
7. Medroxyprogesterone acetate inhibits the cardioprotective effect of estrogen in experimental ischemia-reperfusion injury.
Jeanes HL; Wanikiat P; Sharif I; Gray GA
Menopause; 2006; 13(1):80-6. PubMed ID: 16607102
[TBL] [Abstract][Full Text] [Related]
8. Progestins initiate adverse events of menopausal estrogen therapy.
Thomas T; Rhodin J; Clark L; Garces A
Climacteric; 2003 Dec; 6(4):293-301. PubMed ID: 15011717
[TBL] [Abstract][Full Text] [Related]
9. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
[TBL] [Abstract][Full Text] [Related]
10. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
11. Progestins oppose the effects of estradiol on the endothelin-1 receptor type B in coronary arteries from ovariectomized hyperlipidemic rabbits.
Pedersen SH; Nielsen LB; Mortensen A; Nilas L; Ottesen B
Menopause; 2008; 15(3):503-10. PubMed ID: 18188139
[TBL] [Abstract][Full Text] [Related]
12. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
13. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
[TBL] [Abstract][Full Text] [Related]
14. Conjugated equine estrogens alone, but not in combination with medroxyprogesterone acetate, inhibit aortic connective tissue remodeling after plasma lipid lowering in female monkeys.
Register TC; Adams MR; Golden DL; Clarkson TB
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1164-71. PubMed ID: 9672078
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat.
Shirk RA; Zhang Z; Winneker RC
J Steroid Biochem Mol Biol; 2005 Mar; 94(4):361-8. PubMed ID: 15857755
[TBL] [Abstract][Full Text] [Related]
16. Modulation of coronary vascular resistance in female rabbits by estrogen and progesterone.
Gorodeski GI; Yang T; Levy MN; Goldfarb J; Utian WH
J Soc Gynecol Investig; 1998; 5(4):197-202. PubMed ID: 9699178
[TBL] [Abstract][Full Text] [Related]
17. Medroxyprogesterone acetate prevents the cardioprotective and anti-inflammatory effects of 17beta-estradiol in an in vivo model of myocardial ischemia and reperfusion.
Booth EA; Lucchesi BR
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1408-15. PubMed ID: 17434982
[TBL] [Abstract][Full Text] [Related]
18. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen.
Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
Circulation; 2001 Oct; 104(15):1773-8. PubMed ID: 11591613
[TBL] [Abstract][Full Text] [Related]
19. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
[TBL] [Abstract][Full Text] [Related]
20. A comparison of tibolone and hormone replacement therapy on coronary artery and myocardial function in ovariectomized atherosclerotic monkeys.
Williams JK; Hall J; Anthony MS; Register TC; Reis SE; Clarkson TB
Menopause; 2002; 9(1):41-51. PubMed ID: 11791085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
